Abstract. Several cardiovascular risk factors correlate with adiponectin levels. It is not known whether total homocysteine, folate and g-glutamyl transferase levels correlate with adiponectin. We cross-sectionally analyzed the association between adiponectin and these cardiovascular risk factors in diabetic patients. One hundred and two male inpatients with type 2 diabetes without overt nephropathy or insulin use were studied. In a regression analysis of the quartiles of adiponectin, plasma levels of adiponectin were associated positively with HDL-cholesterol and age, and inversely with body mass index and HbA 1c , but not with total homocysteine, folate or g-glutamyl transferase. Nontraditional cardiovascular risk factors such as homocysteine and folate levels were not associated with adiponectin levels in male type 2 diabetic patients who are not subject to insulin therapy. ADIPONECTIN is a recently identified protein which is produced exclusively by adipocytes [1]. Elevated adiponectin levels are associated with lower risk of atherosclerotic disease [2]. Recent studies show that it has both anti-atherogenic [3,4] and anti-diabetic properties [3][4][5][6]. This may be due to the beneficial effects of adiponectin on metabolic factors. Adiponectin is positively associated with physical activity, age and HDL-cholesterol and inversely with body mass index (BMI) and HbA 1C [7][8][9]. But, it is not known whether some other cardiovascular risk factors, including total homocysteine (tHcy), folate and g-glutamyl transferase (g-GT), correlate with adiponectin levels in type 2 diabetic patients. It has been shown that high tHcy [10,11], low folate [12,13] and high g-GT [14] predict cardiovascular disease. It is suggested that association between tHcy and cardiovascular disease is stronger in diabetic patients than in non-diabetic subjects [15,16].In the present study we analyzed the association between these cardiovascular risk factors and adiponectin levels in male type 2 diabetic patients. Since insulin affects adiponectin [17] and tHcy [18,19], diabetic patients who are not subject to insulin therapy were studied.
Materials and MethodsOne hundred and two Japanese male inpatients with type 2 diabetes who were not subject to insulin therapy were studied. Patients who showed overt nephropathy (serum creatinine>1.2 mg/dl) were excluded from the study because renal dysfunction might elevate adiponectin [20] and tHcy [21]. Blood samples were collected early in the morning. Plasma fast glucose and immunoreactive insulin, serum total cholesterol, triglyceride, creatinine and g-GT, and HbA 1C and white blood cell (WBC) count were measured. Plasma adiponectin levels were measured using human adiponectin ELISA Kit (Otsuka Pharmaceutical Co.,